Fundz

Reneo Pharmaceuticals, Inc. reported raising $25 Million in an initial SEC Form D filing, from an offering of $25 Million

PUBLIC · OKURMay 14, 2019

Amount Raised

$25 Million

$25 Million sold, per SEC Form D (first sale May 14, 2019)

Round Type

Venture

IrvineBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as OnKure Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at OnKure Therapeutics, Inc., and when

A new round usually means OnKure Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OnKure Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OnKure Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OnKure Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OnKure Therapeutics, Inc.

Location

12230 El Camino Real, Suite 230

Irvine, California, United States

About

Reneo Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing therapeutics for patients suffering from a variety of diseases. They are known for the proposed merger with OnKure, Inc. and the subsequent change of their name to OnKure Therapeutics, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OnKure Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for OnKure Therapeutics, Inc.'s next move

See what Strategic adds

OnKure Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.